Raymond James & Associates 23and Me Holding Co. Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in 23and Me Holding Co. stock. As of the latest transaction made, Raymond James & Associates holds 75,614 shares of ME stock, worth $264,649. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75,614
Previous 75,614
-0.0%
Holding current value
$264,649
Previous $29,000
10.34%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ME
# of Institutions
105Shares Held
63.7MCall Options Held
404KPut Options Held
292K-
Vanguard Group Inc Valley Forge, PA15.6MShares$54.5 Million0.0% of portfolio
-
Euclidean Capital LLC New York, NY10.2MShares$35.9 Million0.4% of portfolio
-
Sapphire Ventures, L.L.C. Austin, TX5.29MShares$18.5 Million1.93% of portfolio
-
Black Rock Inc. New York, NY4.66MShares$16.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.25MShares$14.9 Million0.0% of portfolio
About 23andMe Holding Co.
- Ticker ME
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 259,768,000
- Market Cap $909M
- Description
- 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...